Acute Respiratory Distress Syndrome (ARDS) Clinical Trials

Find Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Near You

Study of the Immunological Pathophysiological Mechanisms Associated With Acute Respiratory Distress Syndrome

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Objectives: To characterize the inflammatory profile of patients with ARDS using circulating biomarkers and single-cell RNA sequencing of pulmonary immune cells. The investigators hypothesize that there is a correlation between the profile of serum biomarkers (inflammatory sub-phenotypes), the transcriptome of pulmonary immune cells. Briefly the experimental scheme is as follow: * Population: patients with ARDS under invasive mechanical ventilation in the ICU. * Intervention: 1. Determination of the inflammatory subphenotype on circulatory inflammatory biomarkers. 2. Characterization of inflammation by single cell RNA sequencing on lung immune cells collected on broncho-alveolar fluid.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• ARDS risk factors: bacterial or viral pneumonia, extrapulmonary infection, major trauma, transfusion, inhalation injury, or shock.

• Pulmonary edema not explained by a cardiogenic cause or volume overload.

• Onset of respiratory symptoms within \<7 days.

• Bilateral pulmonary involvement on chest X-ray, CT scan, or ultrasound.

• PaO₂/FiO₂ ≤ 300 assessed with PEEP ≥ 5 cmH₂O.

Locations
Other Locations
France
Hôpital Lariboisière
RECRUITING
Paris
Contact Information
Primary
Pierre-Louis BLOT, MD
pierre-louis.blot@aphp.fr
+331049956565
Backup
Benjamin Chousterman, MD PhD
benjamin.chousterman@aphp.fr
+330149958518
Time Frame
Start Date: 2026-03-26
Estimated Completion Date: 2029-03-26
Participants
Target number of participants: 50
Sponsors
Leads: Assistance Publique - Hôpitaux de Paris

This content was sourced from clinicaltrials.gov